The Relationship Between ICS LABA Administration and Blood Eosinophil Levels in COPD Patient at USU General Hospital

Olivia Monica Deneuve; Andika Pradana; Amira P Tarigan

doi:10.47353/jsocmed.v3i12.180

The Relationship Between ICS LABA Administration and Blood Eosinophil Levels in COPD Patient at USU General Hospital

Olivia Monica Deneuve
Department of Pulmonology and Respiratory Medicine, Faculty of Medicine Universitas Sumatera Utara, Adam Malik General Hospital, Medan Indonesia
Andika Pradana
Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Sumatera Utara, Universitas Sumatera Utara General Hospital, Medan, Indonesia.
Amira P Tarigan
Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Sumatera Utara, Universitas Sumatera Utara General Hospital, Medan, Indonesia

Abstract

Introduction: Blood eosinophil count may predict treatment response in patients with chronic obstructive pulmonary disease (COPD) during acute exacerbations. However, the ability of blood eosinophil counts in stable status to predict eosinophilic.

Method: This was a cohort retrospective study performed Juni-August 2022 to Juni-August 2023. Subject were COPD patients who were treated at the outpatient using ICS LABA therapy. Blood samples measured blood eosinophil levels first and control.

Results: Based on Wilcoxon test test, there was a significant positive positive correlation of eosinophil counts between ICS LABA Administration and Blood Eosinophil Levels in COPD Patient at USU General Hospital.

Conclusion: We demonstrated association between ICS LABA Administration and Blood Eosinophil Levels in COPD Patient (p value = 0.02).

Similar Articles

Lela Khaibirunna A.P, Noni Novisari Soeroso, Desfrina Kasuma, Putri Eyanoer, BRAF Mutation Status and Histopathological Differentiation Patterns in Non–Small Cell Lung Cancer: A Tertiary Referral Center Study in Indonesia , Journal of Society Medicine: Vol. 5 No. 5 (2026): May
Army Zaka Anwary, Indriasari, Role of CRRT (Continuous Renal Replacement Therapy) as Management of Cardiac Arrest Patient with Postpartum Acute Lung Edema and Cardiomyopathy in the ICU , Journal of Society Medicine: Vol. 2 No. 6 (2023): June
Muhammad Hafiz Mahruzza Putra, Refli Hasan, Andika Sitepu, Harris Hasan, Andre Pasha Ketaren, Cut Aryfa Andra, Abdul Halim Raynaldo, Kamal Kharrazi Ilyas, Relationship between Coronary Artery Calcium Score (CACS) and Diastolic Dysfunction in Patients with Stable Coronary Heart Disease at Adam Malik General Hospital Medan , Journal of Society Medicine: Vol. 4 No. 6 (2025): June
Qien Jovan Fatraya, Zainal Safri , Anggia Chairuddin Lubis , The Relationship Between Elevated Systemic Immune-Inflammatory Index (SII) and the Severity of Coronary Lesions in Chronic Coronary Syndrome (CCS) Patients Undergoing Coronary Angiography at Haji Adam Malik Hospital Medan , Journal of Society Medicine: Vol. 4 No. 6 (2025): June
Lastri Hillary, Ali Nafiah Nasution, Anggia Chairuddin Lubis, Correlation of P Wave Dispersion and Quality of Life of Heart Failure Due to Coronary Heart Disease Patient in Haji Adam Malik General Hospital , Journal of Society Medicine: Vol. 3 No. 4 (2024): April
Sri Rahmadhona, Bastian Lubis , Anesthetic Management of Cavernous Sinus Meningioma with Pre-existing Cranial Nerve Deficits: A Case Report , Journal of Society Medicine: Vol. 5 No. 1 (2026): January
Novery Simbolon, Pandia Pandiaman, Pradana Andika , Factors Affecting Lung Function in Patients with Drug-Sensitive Tuberculosis after Treatment. , Journal of Society Medicine: Vol. 3 No. 10 (2024): Oktober
Qadri Fauzi Tanjung, Agus Prima, History of Cuppping in Medical Perspective , Journal of Society Medicine: Vol. 1 No. 1 (2022): October
Adityo Prabowo, Use of Chest X-Ray (CXR) in Covid-19 Screening as A Modalities , Journal of Society Medicine: Vol. 1 No. 2 (2022): November
Dalimunthe Dina A, Sisilia K Dewi, Cutaneous Disorder Associated Diabetes Mellitus , Journal of Society Medicine: Vol. 4 No. 1 (2025): January

<< < 2 3 4 5 6 7 8 9 10 11 > >>

You may also start an advanced similarity search for this article.

PDF

Published at

31. December 2024
https://doi.org/10.47353/jsocmed.v3i12.180
Issue:

Vol. 3 No. 12 (2024): December
Section:

Articles
Keywords:

Blood, Eosinophilia Exacerbation COPD (Chronic Obstructive Pulmonary Disease) GOLD
References:

Mathers CD, Loncar D. Projections of global mortality and burden of disease. PLoS Med 2006; 11: 4-42.

Chen W, Thomas J, Sadatsafavi M, FitzGerald JM. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Lancet Respir Med. 2015; 8: 9-631.

Pascoe S, Locantore N, Dransfield MT, Barnes NC, Pavord ID. Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials. Lancet Respir Med. 2015; 6: 42-435.

Bafadhel M, Peterson S, De Blas MA, Singh D, Calverley PMA, Pavord ID, et al. Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials. Lancet Respir Med. 2018; 2: 26-117.

Hartl S, Breyer MK, Burghuber OC, Hacker S, Schrott A, Rudzicki W, et al. Blood eosinophil count in the general population: typical values and potential confounders. Eur Respir J. 2020; 5: 874-1901.

Kolsum U, Southworth T, Jackson N, Singh D. Blood eosinophil counts in COPD patients compared to controls. Eur Respir J. 2019; 4: 633-1900.

Celli B, Fabbri L, Criner G, Wedzicha JA, Martinez FJ, Agusti A, et al. Definition and nomenclature of chronic obstructive pulmonary disease: time for its revision. Am J Respir Crit Care Med. 2022; 205: 1-20.

Agusti A, Melen E, DeMeo DL, Breyer-Kohansal R, Faner R, Wouters EF, et al. Pathogenesis of chronic obstructive pulmonary disease: understanding the contributions of gene-environment interactions across the lifespan. Lancet Respir Med. 2022; 5: 24-512.

Yang IA, Jenkins CR, Salvi SS. Chronic obstructive pulmonary disease in never-smokers: risk factors, pathogenesis, and implications for prevention and treatment. Lancet Respir Med. 2022; 5: 497-511.

Cho MH, Hobbs BD, Silverman EK. Genetics of chronic obstructive pulmonary disease: understanding the pathobiology and heterogeneity of a complex disorder. Lancet Respir Med. 2022; 5: 96-485.

Bardsen T, Roksund OD, Benestad MR, Clemm HH, Halvorsen T, Røksund AB, Markestad T. Tracking of lung function from 10 to 35 years after being born extremely preterm or with extremely low birth weight. Thorax. 2022; 8: 8-790.

Eisner MD, Anthonisen N, Coultas D, Perez-Padilla R, Buist S, Mannino D, et al. An official American Thoracic Society public policy statement: novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010; 15: 693-718.

Li J, Sun S, Tang R, Qiu H, Wang W, Yan L, et al. Major air pollutants and risk of COPD exacerbations: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2016; 11: 91-3079.

Erry P. Korelasi antara eosinofil darah dan sputum pasien penyakit paru obstruksi kronik (PPOK) di Rumah Sakit Rujukan Respirasi Nasional Persahabatan. Jakarta. 2019; 1: 1-50.

Shibata Y. Role of ICS/LABA on COPD treatment. Japan. 2016; 1: 1-30.

Babu KS, Kastelik JA, Morjaria JB. Inhaled corticosteroid in chronic obstructive pulmonary disease. J Chron Obstruct Pulmon Dis. 2014; 4: 137-821.
Share:

Z

Deneuve, O. M., Pradana, A., & Tarigan, A. P. (2024). The Relationship Between ICS LABA Administration and Blood Eosinophil Levels in COPD Patient at USU General Hospital. Journal of Society Medicine, 3(12), 374–378. https://doi.org/10.47353/jsocmed.v3i12.180